iBio (IBIO) Other Accumulated Expenses (2011 - 2024)

iBio (IBIO) has 7 years of Other Accumulated Expenses data on file, last reported at $460000.0 in Q2 2024.

• On a quarterly basis, Other Accumulated Expenses rose 130.0% year-over-year to $460000.0 in Q2 2024; TTM through Jun 2024 was $460000.0, a 130.0% increase from a year earlier, with the FY2024 full-year figure at $460000.0, up 130.0% from the prior year.
• Other Accumulated Expenses for Q2 2024 stood at $460000.0, up from $200000.0 in the prior quarter.
• Over the last five years, Other Accumulated Expenses for IBIO reached as high as $460000.0 in Q2 2024 and fell as low as $136000.0 in Q2 2021.
• Historically, Other Accumulated Expenses has averaged $238400.0 across 5 years, with a median of $200000.0 in 2023.
• Across the five-year window, Other Accumulated Expenses slipped 18.56% in 2021 and jumped 130.0% in 2024, its largest moves.
• Year by year, Other Accumulated Expenses stood at $167000.0 in 2020, then dropped by 18.56% to $136000.0 in 2021, then soared by 68.38% to $229000.0 in 2022, then slipped by 12.66% to $200000.0 in 2023, then soared by 130.0% to $460000.0 in 2024.
• Per Business Quant data, the three most recent Other Accumulated Expenses figures were $460000.0 in Q2 2024, $200000.0 in Q2 2023, and $229000.0 in Q2 2022.